CCNB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.091200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.935600E-01
Normal-vs-Stage2
1.918790E-01
Normal-vs-Stage3
5.676200E-01
Normal-vs-Stage4
4.683600E-01
Stage1-vs-Stage2
4.316000E-01
Stage1-vs-Stage3
8.539800E-01
Stage1-vs-Stage4
9.974600E-01
Stage2-vs-Stage3
4.027000E-01
Stage2-vs-Stage4
5.221000E-01
Stage3-vs-Stage4
8.768000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.045000E-01
Normal-vs-AfricanAmerican
3.904800E-01
Normal-vs-Asian
1.373430E-01
Caucasian-vs-AfricanAmerican
2.714000E-01
Caucasian-vs-Asian
7.001700E-02
AfricanAmerican-vs-Asian
4.890200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.133000E-01
Normal-vs-Female
2.148200E-01
Male-vs-Female
8.022000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.279800E-01
Normal-vs-Age(41-60Yrs)
1.862210E-01
Normal-vs-Age(61-80Yrs)
2.251600E-01
Normal-vs-Age(81-100Yrs)
2.219800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.978800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.743800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.181400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.855600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.553000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.646200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.804600E-01
Normal-vs-Daily Drinker
2.119200E-01
Normal-vs-Weekly Drinker
3.934000E-01
Normal-vs-Occasional Drinker
1.100990E-01
Normal-vs-Social Drinker
2.289400E-01
Non Drinker-vs-Daily Drinker
5.852400E-01
Non Drinker-vs-Weekly Drinker
9.154200E-01
Non Drinker-vs-Occasional Drinker
5.835200E-01
Non Drinker-vs-Social Drinker
7.260800E-01
Daily Drinker-vs-Weekly Drinker
7.626800E-01
Daily Drinker-vs-Occasional Drinker
9.856400E-01
Daily Drinker-vs-Social Drinker
8.945000E-01
Weekly Drinker-vs-Occasional Drinker
7.599800E-01
Weekly Drinker-vs-Social Drinker
8.652400E-01
Occasional Drinker-vs-Social Drinker
8.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.094400E-01
Normal-vs-Grade 2
7.026800E-01
Normal-vs-Grade 3
7.517400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.159540E-04
Grade 1-vs-Grade 3
8.35500000000433E-05
Grade 1-vs-Grade 4
6.094400E-01
Grade 2-vs-Grade 3
1.757620E-01
Grade 2-vs-Grade 4
7.026800E-01
Grade 3-vs-Grade 4
7.517400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.538800E-01
Normal-vs-NonDiabetic
1.746440E-01
Diabetic-vs-NonDiabetic
5.165600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.997800E-02
Normal-vs-NoPancreatitis
2.342200E-01
Pancreatitis-vs-NoPancreatitis
8.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.238800E-01
Normal-vs-N1
2.192600E-01
N0-vs-N1
5.451800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.575600E-02
Normal-vs-TP53-NonMutant
2.618400E-01
TP53-Mutant-vs-TP53-NonMutant
1.51569999999879E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
